The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GMP Biologics Market Research Report 2024
Synopsis
GMP Biologics refers to biopharmaceuticals produced following Good Manufacturing Practice (GMP) standards. These biologics, derived from living organisms, undergo strict quality control to ensure safety and efficacy in medical applications.
The global GMP Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for GMP Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GMP Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for GMP Biologics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of GMP Biologics include Creative Diagnostics, Fisher Bioservices(Thermo Fisher Scientific), Polpharma Biologics, Intertek, HemaCare and AGC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GMP Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Biologics.
Report Scope
The GMP Biologics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Diagnostics
Fisher Bioservices(Thermo Fisher Scientific)
Polpharma Biologics
Intertek
HemaCare
AGC
Segment by Type
Recombinant Protein
Biosynthesized Hormones
Genetically Engineered Vaccines
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
GMP Biologics refers to biopharmaceuticals produced following Good Manufacturing Practice (GMP) standards. These biologics, derived from living organisms, undergo strict quality control to ensure safety and efficacy in medical applications.
The global GMP Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for GMP Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GMP Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for GMP Biologics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of GMP Biologics include Creative Diagnostics, Fisher Bioservices(Thermo Fisher Scientific), Polpharma Biologics, Intertek, HemaCare and AGC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GMP Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Biologics.
Report Scope
The GMP Biologics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Diagnostics
Fisher Bioservices(Thermo Fisher Scientific)
Polpharma Biologics
Intertek
HemaCare
AGC
Segment by Type
Recombinant Protein
Biosynthesized Hormones
Genetically Engineered Vaccines
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Biologics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Recombinant Protein
1.2.3 Biosynthesized Hormones
1.2.4 Genetically Engineered Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global GMP Biologics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Biologics Market Perspective (2019-2030)
2.2 GMP Biologics Growth Trends by Region
2.2.1 Global GMP Biologics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 GMP Biologics Historic Market Size by Region (2019-2024)
2.2.3 GMP Biologics Forecasted Market Size by Region (2025-2030)
2.3 GMP Biologics Market Dynamics
2.3.1 GMP Biologics Industry Trends
2.3.2 GMP Biologics Market Drivers
2.3.3 GMP Biologics Market Challenges
2.3.4 GMP Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP Biologics Players by Revenue
3.1.1 Global Top GMP Biologics Players by Revenue (2019-2024)
3.1.2 Global GMP Biologics Revenue Market Share by Players (2019-2024)
3.2 Global GMP Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GMP Biologics Revenue
3.4 Global GMP Biologics Market Concentration Ratio
3.4.1 Global GMP Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Biologics Revenue in 2023
3.5 GMP Biologics Key Players Head office and Area Served
3.6 Key Players GMP Biologics Product Solution and Service
3.7 Date of Enter into GMP Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Biologics Breakdown Data by Type
4.1 Global GMP Biologics Historic Market Size by Type (2019-2024)
4.2 Global GMP Biologics Forecasted Market Size by Type (2025-2030)
5 GMP Biologics Breakdown Data by Application
5.1 Global GMP Biologics Historic Market Size by Application (2019-2024)
5.2 Global GMP Biologics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America GMP Biologics Market Size (2019-2030)
6.2 North America GMP Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America GMP Biologics Market Size by Country (2019-2024)
6.4 North America GMP Biologics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP Biologics Market Size (2019-2030)
7.2 Europe GMP Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe GMP Biologics Market Size by Country (2019-2024)
7.4 Europe GMP Biologics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GMP Biologics Market Size (2019-2030)
8.2 Asia-Pacific GMP Biologics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific GMP Biologics Market Size by Region (2019-2024)
8.4 Asia-Pacific GMP Biologics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GMP Biologics Market Size (2019-2030)
9.2 Latin America GMP Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America GMP Biologics Market Size by Country (2019-2024)
9.4 Latin America GMP Biologics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP Biologics Market Size (2019-2030)
10.2 Middle East & Africa GMP Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa GMP Biologics Market Size by Country (2019-2024)
10.4 Middle East & Africa GMP Biologics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Diagnostics
11.1.1 Creative Diagnostics Company Detail
11.1.2 Creative Diagnostics Business Overview
11.1.3 Creative Diagnostics GMP Biologics Introduction
11.1.4 Creative Diagnostics Revenue in GMP Biologics Business (2019-2024)
11.1.5 Creative Diagnostics Recent Development
11.2 Fisher Bioservices(Thermo Fisher Scientific)
11.2.1 Fisher Bioservices(Thermo Fisher Scientific) Company Detail
11.2.2 Fisher Bioservices(Thermo Fisher Scientific) Business Overview
11.2.3 Fisher Bioservices(Thermo Fisher Scientific) GMP Biologics Introduction
11.2.4 Fisher Bioservices(Thermo Fisher Scientific) Revenue in GMP Biologics Business (2019-2024)
11.2.5 Fisher Bioservices(Thermo Fisher Scientific) Recent Development
11.3 Polpharma Biologics
11.3.1 Polpharma Biologics Company Detail
11.3.2 Polpharma Biologics Business Overview
11.3.3 Polpharma Biologics GMP Biologics Introduction
11.3.4 Polpharma Biologics Revenue in GMP Biologics Business (2019-2024)
11.3.5 Polpharma Biologics Recent Development
11.4 Intertek
11.4.1 Intertek Company Detail
11.4.2 Intertek Business Overview
11.4.3 Intertek GMP Biologics Introduction
11.4.4 Intertek Revenue in GMP Biologics Business (2019-2024)
11.4.5 Intertek Recent Development
11.5 HemaCare
11.5.1 HemaCare Company Detail
11.5.2 HemaCare Business Overview
11.5.3 HemaCare GMP Biologics Introduction
11.5.4 HemaCare Revenue in GMP Biologics Business (2019-2024)
11.5.5 HemaCare Recent Development
11.6 AGC
11.6.1 AGC Company Detail
11.6.2 AGC Business Overview
11.6.3 AGC GMP Biologics Introduction
11.6.4 AGC Revenue in GMP Biologics Business (2019-2024)
11.6.5 AGC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global GMP Biologics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Recombinant Protein
Table 3. Key Players of Biosynthesized Hormones
Table 4. Key Players of Genetically Engineered Vaccines
Table 5. Key Players of Others
Table 6. Global GMP Biologics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global GMP Biologics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global GMP Biologics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global GMP Biologics Market Share by Region (2019-2024)
Table 10. Global GMP Biologics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global GMP Biologics Market Share by Region (2025-2030)
Table 12. GMP Biologics Market Trends
Table 13. GMP Biologics Market Drivers
Table 14. GMP Biologics Market Challenges
Table 15. GMP Biologics Market Restraints
Table 16. Global GMP Biologics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global GMP Biologics Market Share by Players (2019-2024)
Table 18. Global Top GMP Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Biologics as of 2023)
Table 19. Ranking of Global Top GMP Biologics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by GMP Biologics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players GMP Biologics Product Solution and Service
Table 23. Date of Enter into GMP Biologics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global GMP Biologics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global GMP Biologics Revenue Market Share by Type (2019-2024)
Table 27. Global GMP Biologics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global GMP Biologics Revenue Market Share by Type (2025-2030)
Table 29. Global GMP Biologics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global GMP Biologics Revenue Market Share by Application (2019-2024)
Table 31. Global GMP Biologics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global GMP Biologics Revenue Market Share by Application (2025-2030)
Table 33. North America GMP Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America GMP Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America GMP Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe GMP Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe GMP Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe GMP Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific GMP Biologics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific GMP Biologics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific GMP Biologics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America GMP Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America GMP Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America GMP Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa GMP Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa GMP Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa GMP Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Creative Diagnostics Company Detail
Table 49. Creative Diagnostics Business Overview
Table 50. Creative Diagnostics GMP Biologics Product
Table 51. Creative Diagnostics Revenue in GMP Biologics Business (2019-2024) & (US$ Million)
Table 52. Creative Diagnostics Recent Development
Table 53. Fisher Bioservices(Thermo Fisher Scientific) Company Detail
Table 54. Fisher Bioservices(Thermo Fisher Scientific) Business Overview
Table 55. Fisher Bioservices(Thermo Fisher Scientific) GMP Biologics Product
Table 56. Fisher Bioservices(Thermo Fisher Scientific) Revenue in GMP Biologics Business (2019-2024) & (US$ Million)
Table 57. Fisher Bioservices(Thermo Fisher Scientific) Recent Development
Table 58. Polpharma Biologics Company Detail
Table 59. Polpharma Biologics Business Overview
Table 60. Polpharma Biologics GMP Biologics Product
Table 61. Polpharma Biologics Revenue in GMP Biologics Business (2019-2024) & (US$ Million)
Table 62. Polpharma Biologics Recent Development
Table 63. Intertek Company Detail
Table 64. Intertek Business Overview
Table 65. Intertek GMP Biologics Product
Table 66. Intertek Revenue in GMP Biologics Business (2019-2024) & (US$ Million)
Table 67. Intertek Recent Development
Table 68. HemaCare Company Detail
Table 69. HemaCare Business Overview
Table 70. HemaCare GMP Biologics Product
Table 71. HemaCare Revenue in GMP Biologics Business (2019-2024) & (US$ Million)
Table 72. HemaCare Recent Development
Table 73. AGC Company Detail
Table 74. AGC Business Overview
Table 75. AGC GMP Biologics Product
Table 76. AGC Revenue in GMP Biologics Business (2019-2024) & (US$ Million)
Table 77. AGC Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GMP Biologics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global GMP Biologics Market Share by Type: 2023 VS 2030
Figure 3. Recombinant Protein Features
Figure 4. Biosynthesized Hormones Features
Figure 5. Genetically Engineered Vaccines Features
Figure 6. Others Features
Figure 7. Global GMP Biologics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global GMP Biologics Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. GMP Biologics Report Years Considered
Figure 13. Global GMP Biologics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global GMP Biologics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global GMP Biologics Market Share by Region: 2023 VS 2030
Figure 16. Global GMP Biologics Market Share by Players in 2023
Figure 17. Global Top GMP Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Biologics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by GMP Biologics Revenue in 2023
Figure 19. North America GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America GMP Biologics Market Share by Country (2019-2030)
Figure 21. United States GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe GMP Biologics Market Share by Country (2019-2030)
Figure 25. Germany GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific GMP Biologics Market Share by Region (2019-2030)
Figure 33. China GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America GMP Biologics Market Share by Country (2019-2030)
Figure 41. Mexico GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa GMP Biologics Market Share by Country (2019-2030)
Figure 45. Turkey GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia GMP Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Creative Diagnostics Revenue Growth Rate in GMP Biologics Business (2019-2024)
Figure 48. Fisher Bioservices(Thermo Fisher Scientific) Revenue Growth Rate in GMP Biologics Business (2019-2024)
Figure 49. Polpharma Biologics Revenue Growth Rate in GMP Biologics Business (2019-2024)
Figure 50. Intertek Revenue Growth Rate in GMP Biologics Business (2019-2024)
Figure 51. HemaCare Revenue Growth Rate in GMP Biologics Business (2019-2024)
Figure 52. AGC Revenue Growth Rate in GMP Biologics Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
